Bio pharmaceuticals steroids

Joseph Bonventre's research focuses primarily on the study of kidney injury and repair and signal transduction, with a special emphasis on the role of inflammation, biomarkers and stem cells. He has more than 350 original research publications, 150 reviews/chapters and editorials and 3 books. His recent work also involves the generation of kidney organoids from stem cells and their use in kidney disease modeling. He has been elected to the American Society of Clinical Investigation (ASCI), the Association of American Physicians (AAP), the American Clinical and Climatological Association (ACCA) and the American Institute for Medical and Biological Engineering (AMBIE). He is a member of the Executive Committee of the Harvard Stem Cell Institute (HSCI).

Bio pharmaceuticals steroids

bio pharmaceuticals steroids

Media:

bio pharmaceuticals steroidsbio pharmaceuticals steroidsbio pharmaceuticals steroidsbio pharmaceuticals steroidsbio pharmaceuticals steroids